Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine
URGENT: VOLUNTARY DRUG RECALL
|Description ||NDC ||Lot# ||Exp/Date|
|Lamotrigine Tablets 100mg ||51672413101 ||331771 ||6/1/2021|
Taro Pharmaceuticals U.S.A. Inc. is voluntarily recalling one (1) lot of Lamotrigine 100 mg Tablets to the consumer level. This single lot of Lamotrigine was found to have been cross-contaminated with a small amount of another drug substance (Enalapril Maleate) used to manufacture another product at the same facility. A listing of the NDC and impacted lot number is identified. Affected product started shipping August 2019.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug products.
This recall is being conducted with the knowledge of the U.S Food and Drug Administration.
Taro: Taro Customer Service 866-923-4914